Skip to content

To compare whether Dexmedetomidine added to Ropivacaine or Ropivacaine alone in Transverse Abdominis Plane block in patients undergoing Laparoscopic cholecystectomy will be better in alleviating haemodynamic response and provide post operative analgesia

Efficacy of Dexmedetomidine added to Ropivacaine for Transverse Abdominis Plane block on hemodynamic response and reduction in post operative analgesia in Laparoscopic Cholecystectomy - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061166
Enrollment
126
Registered
2024-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K800- Calculus of gallbladder with acutecholecystitis

Interventions

Intervention1: 0.5 mcg/kg of Dexmedetomidine added to 0.2% Ropivacaine in TAP block: Transverse Abdominis Plane(TAP) block given with 15ml of 0.5mcg/kg of dexmedetomidine added to 0.2% Ropivacaine in

Sponsors

Rajendra Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient posted for Laparoscopic Cholecystectomy 2.Written and informed consent 3.ASA grade 1 and 2 4.Patient not on antiplatelet or anticoagulant drugs 5.Weight > 50kg

Exclusion criteria

Exclusion criteria: 1.Patient refusal 2.Coagulation disorder 3.Allergy to Local Anaesthetic

Design outcomes

Primary

MeasureTime frame
1.To compare hemodynamic response in all three groups 2.To compare post operative analgesia in all the three groupsTimepoint: 1.From the time of induction till extubation 2.From the time of extubation to 24 hours

Secondary

MeasureTime frame
To compare post operative nausea and vomiting (PONV) in all the three groupsTimepoint: From the time of extubation to 24 hours

Countries

India

Contacts

Public ContactDr Priyanka Shrivastava

Rajendra Institute of Medical Sciences

drkmukesh@gmail.com8709135297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026